Collaboration Details definition

Collaboration Details means Details (as defined in the Collaboration Agreement) provided by Ironwood or Forest, as the case may be, pursuant to the Collaboration Agreement.
Sample 1

Examples of Collaboration Details in a sentence

  • Collaboration Details: Provide details of the relationship between the academic and partner and explain how this partnership benefits the project and the student.

  • The institutional assessment broadly comprised of organisational and financial sustainability assessment.

  • Yes NoMy project does not include any Collaborating InstitutionsSampleCollaboration Details spreadsheetDownload the "Collaboration Details template.xlsx" from: https://drive.google.com/file/d/16JzdfZyl7ao4TlHf-t5e-6wHgg4ZjdL1/view?usp=sharing Fill in the spreadsheet, save according to the file naming convention and upload the completed spreadsheet below.

  • Upload: Collaboration Details spreadsheetUse file naming convention: UA PI last name_Collaborations_YY-MM-DD ***PLEASE NOTE: You can't delete files that have already been uploaded.

  • Section 5: Collaboration Details If you are formally collaborating with other entities, please complete sub-sections 5.2 and 5.3 of the application.

  • Predictors of Student Success in Canadian Polytechnics and CEGEPs. Canadian Journal of Higher Education / Revue canadienne d'enseignement supérieur, 48(2), 74–91.

  • Information Management Strategy/Supply Chain Collaboration Details Electronic point of sale (EPoS)Share market data across supply chain players (Mason-Jones 1999; Dejonckheere et al.

  • Notwithstanding any provision of the Collaboration Agreement, any Commercialization Plan or any other agreement (including [**]) between Ironwood and Forest (or their respective Affiliates) to the contrary, any Share Adjustment with respect to Calendar Years 2018 and any Calendar Year thereafter shall be forgiven in full notwithstanding any failure by Ironwood or Forest, as applicable, to conduct Collaboration Details as required pursuant to the Collaboration Agreement.

  • Be certain to address: objectives methodology hypotheses responsibilities and contributions of each team member   Collaboration Details (Max 1 page) Describe the nature of the collaboration (e.g. newly formed, established, etc.).

  • Feedback and testingOther The training and guidance of teaching assistants Collaboration Details on the contents of each construct, including the items which are not scored are outlined below.

Related to Collaboration Details

  • Collaboration Compound means any of the following: (a) FG-4592, (b) any HIF Compound (other than FG-4592) that is added to this Agreement pursuant to Section 3.6, and (c) any salts, esters, complexes, chelates, crystalline and amorphous morphic forms, pegylated forms, enantiomers (excluding regioisomers), prodrugs, solvates, metabolites and catabolites of any of the foregoing ((a) or (b)).

  • Collaboration Product means a pharmaceutical product containing or comprising Compound in any dosage form alone, or in combination with, one or more other pharmaceutically active ingredients, and any and all Improvements thereto.

  • Collaboration has the meaning set forth in Section 2.1.

  • Development Program means the implementation of the development plan.

  • Collaboration Target means the Initial Collaboration Targets set forth on Exhibit F and any Additional Target or Substitute Target that is selected in accordance with Section 3.3 of this Agreement.

  • Development Candidate means a Collaboration Compound designated by Biogen Idec as a Development Candidate in accordance with Section 2.6.

  • Development Activities means any activity, including the discharge of dredged or fill material, which results directly in a more than de minimus change in the hydrologic regime, bottom contour, or the type, distribution or diversity of hydrophytic vegetation, or which impairs the flow, reach, or circulation of surface water within wetlands or other waters;

  • Development Plan has the meaning set forth in Section 3.2.

  • Collaboration Know-How means all Know-How conceived, discovered, developed or otherwise made by or on behalf of a particular Party or any of its Affiliates or permitted subcontractors of any of the foregoing (solely or jointly by or on behalf of a particular Party or any of its Affiliates or permitted subcontractors of any of the foregoing) in the course of [***].

  • Clinical Trials means a controlled study in humans of the safety or efficacy of a Product, and includes, without limitation, such clinical trials as are designed to support expanded labeling or to satisfy the requirements of an Agency in connection with any Product Approval and any other human study used in research and Development of a Product.

  • Collaborative matter means a dispute, transaction, claim, problem, or issue for resolution, including a dispute, claim, or issue in a proceeding, that is described in a collaborative law participation agreement and arises under the family or domestic relations law of this state, including any of the following:

  • Development Team means the entities and professionals assembled to develop and manage the Project, typically including the Applicant, Owner, Developer(s), Co-Developer(s) and general partner or any other related entities in which the Developer or Co-Developer has an identity of interest or a Controlling Interest.

  • Phase III Clinical Trials means a Clinical Trial for the Product on sufficient numbers of patients to generate safety and efficacy data to support Regulatory Approval in the proposed therapeutic indication, conducted in accordance with current good clinical practices and in accordance with a protocol that has been reviewed by the FDA and reflects any comments or concerns raised by the same.

  • Commercialization Plan has the meaning set forth in Section 6.2.

  • Research Program has the meaning set forth in Section 2.1.

  • Research Program Term has the meaning set forth in Section 2.2.

  • Research Plan shall have the meaning set forth in Section 2.1.

  • Clinical Trial means a Phase I Clinical Trial, Phase II Clinical Trial or Phase III Clinical Trial, or any post-approval human clinical trial, as applicable.

  • Development Phase means the period before a vehicle type is type approved.

  • Phase I Clinical Trial means a clinical trial conducted in healthy humans or patients, which clinical trial is designed to establish the safety, drug-drug interactions and/or pharmacokinetics of an investigational drug given its intended use, and to support continued testing of such drug in Phase II Clinical Trials.

  • Research Period means the research period as described in the Commissioned Research Plan. In accordance with the provisions of this Agreement, in the event that the Agreement ended prior to the completion date of the research originally set, the date the Agreement ends shall be read as the research period.

  • Phase IV Clinical Trial means a Clinical Trial conducted after a Product achieves Regulatory Approval, carried out for purposes of conducting safety surveillance and ongoing technical support of the Product.

  • Phase III Clinical Trial means a human clinical trial, the principal purpose of which is to demonstrate clinically and statistically the efficacy and safety of a Licensed Product for one or more indications in order to obtain Marketing Approval of such Licensed Product for such indication(s), as further defined in 21 C.F.R. §312.21 or a similar clinical study in a country other than the United States.

  • Clinical Study means a Phase I Study, Phase II Study, Phase III Study, or Pivotal Study, as applicable; but excluding any Post-Approval Studies.

  • Commercialization or “Commercialize” means activities directed to marketing, promoting, research and development as required, manufacturing for sale, offering for sale, distributing, importing or selling a product, including sub-licensing or sub-contracting of these activities.

  • Collaboration Term has the meaning set forth in Section 2.1(h).